Litcius/Paper detail

Impact of comorbidities in the response of atopic patients treated with dupilumab: a real‐life study up to 36 weeks

Luca Mastorino, Vania L. CANTAFIO DUÒ, Cristina VECCO, Federica Gelato, Susanna Giordano, Gabriele Roccuzzo, Giovanni Cavaliere, Gianluca Avallone, Michela Ortoncelli, Simone Ribero, Pietro Quaglino

2022Journal of the European Academy of Dermatology and Venereology20 citationsDOI

Topics & Concepts

MedicineDupilumabUniversity hospitalDermatologyAtopic dermatitisFamily medicineDermatology and Skin DiseasesAllergic Rhinitis and SensitizationAsthma and respiratory diseases
Impact of comorbidities in the response of atopic patients treated with dupilumab: a real‐life study up to 36 weeks | Litcius